Aneurysm Wall Histology Registry

NCT ID: NCT01444664

Last Updated: 2016-03-24

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE4

Total Enrollment

24 participants

Study Classification

INTERVENTIONAL

Study Start Date

2010-06-30

Study Completion Date

2015-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this prospective registry is to determine if patients harboring intracranial aneurysms have any predictive markers between aneurysm wall tissue, cerebrospinal fluid and blood plasma.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

To design a registry to evaluate the wall of intracranial aneurysms during open surgical clipping by direct photographic appearance, wall biopsy samples, CSF and blood plasma fluid collection (Interleukins; IL-8/ Matrix Metalloproteinase; MMP-9) for complete evaluation and comparison.

The focus of the registry will be to determine the presence of aneurysmal wall defects, mural clot, atherosclerotic and atheroma, wall permeability and delamination. These findings will then be correlated to the collected CSF and blood values to determine if there is any direct features of the aneurysm wall that would predict any of the reported post embolic syndromes. The collected data can also be correlated to the peroperative imaging, (MRI, CT and Angiogram).

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Brain Aneurysm

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Aneurysm

Group Type EXPERIMENTAL

Surgical Clipping of Aneurysm

Intervention Type PROCEDURE

Surgical clipping of intracranial aneurysm

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Surgical Clipping of Aneurysm

Surgical clipping of intracranial aneurysm

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient \> 18 years but \< 80 years of age
* Patient with an unruptured Intracranial aneurysm 8mm or larger
* Patient that surgical exposure and clipping will be the primary treatment option

Exclusion Criteria

* Any patient that has a ruptured intracranial aneurysm
* Any Pediatric patients
* Any patient presenting with any pre-treatment intracranial lesions

* Vascular malformations
* Hemorrhage
* Normal Pressure Hydrocephalus
* Obstructive Hydrocephalus
* White matter disease
* Tumors
* Trauma
* Other vascular type lesions
* Any meningitis type symptoms
* Medical or surgical co-morbidities such that the patient's life expectancy is less than 1 year
* Inability to obtain consent
Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Albany Medical College

OTHER

Sponsor Role collaborator

Northwestern University

OTHER

Sponsor Role collaborator

Stony Brook University

OTHER

Sponsor Role collaborator

Royal University Hospital Foundation

OTHER

Sponsor Role collaborator

Indiana University

OTHER

Sponsor Role collaborator

Providence Health & Services

OTHER

Sponsor Role collaborator

University of Illinois at Chicago

OTHER

Sponsor Role collaborator

Vanderbilt University

OTHER

Sponsor Role collaborator

Methodist Health System

OTHER

Sponsor Role collaborator

Medical University of South Carolina

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Henry Woo

Role: PRINCIPAL_INVESTIGATOR

SUNY - Stonybrook

Arthur Adam, MD

Role: PRINCIPAL_INVESTIGATOR

Baptist Hospital

Mike Kelly

Role: PRINCIPAL_INVESTIGATOR

Royal University Hospital Foundation

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Northwestern University

Chicago, Illinois, United States

Site Status

University Of Illinois

Chicago, Illinois, United States

Site Status

Goodman Campbell

Indianapolis, Indiana, United States

Site Status

Albany Medical Center

Albany, New York, United States

Site Status

SUNY - Stonybrook University Medical Center

Stony Brook, New York, United States

Site Status

Providence Health

Portland, Oregon, United States

Site Status

Medical University of South Carolina

Charleston, South Carolina, United States

Site Status

Methodist Healthcare - Memphis

Memphis, Tennessee, United States

Site Status

Vanderbilt University

Nashville, Tennessee, United States

Site Status

Royal University Hospital

Saskatoon, Ontario, Canada

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States Canada

References

Explore related publications, articles, or registry entries linked to this study.

Weir B. Unruptured intracranial aneurysms: a review. J Neurosurg. 2002 Jan;96(1):3-42. doi: 10.3171/jns.2002.96.1.0003.

Reference Type BACKGROUND
PMID: 11794601 (View on PubMed)

Ronkainen A, Hernesniemi J. Subarachnoid haemorrhage of unknown aetiology. Acta Neurochir (Wien). 1992;119(1-4):29-34. doi: 10.1007/BF01541778.

Reference Type BACKGROUND
PMID: 1481749 (View on PubMed)

STEHBENS WE. ANEURYSMS AND ANATOMICAL VARIATION OF CEREBRAL ARTERIES. Arch Pathol. 1963 Jan;75:45-64. No abstract available.

Reference Type BACKGROUND
PMID: 14087271 (View on PubMed)

Brisman JL, Song JK, Newell DW. Cerebral aneurysms. N Engl J Med. 2006 Aug 31;355(9):928-39. doi: 10.1056/NEJMra052760. No abstract available.

Reference Type BACKGROUND
PMID: 16943405 (View on PubMed)

Juvela S, Hillbom M, Numminen H, Koskinen P. Cigarette smoking and alcohol consumption as risk factors for aneurysmal subarachnoid hemorrhage. Stroke. 1993 May;24(5):639-46. doi: 10.1161/01.str.24.5.639.

Reference Type BACKGROUND
PMID: 8488517 (View on PubMed)

Juvela S. Prehemorrhage risk factors for fatal intracranial aneurysm rupture. Stroke. 2003 Aug;34(8):1852-7. doi: 10.1161/01.STR.0000080380.56799.DD. Epub 2003 Jun 26.

Reference Type BACKGROUND
PMID: 12829865 (View on PubMed)

Sahs AL. Observations on the pathology of saccular aneurysms. J Neurosurg. 1966 Apr;24(4):792-806. doi: 10.3171/jns.1966.24.4.0792. No abstract available.

Reference Type BACKGROUND
PMID: 5934137 (View on PubMed)

Scanarini M, Mingrino S, Giordano R, Baroni A. Histological and ultrastructural study of intracranial saccular aneurysmal wall. Acta Neurochir (Wien). 1978;43(3-4):171-82. doi: 10.1007/BF01587953.

Reference Type BACKGROUND
PMID: 707175 (View on PubMed)

Krex D, Schackert HK, Schackert G. Genesis of cerebral aneurysms--an update. Acta Neurochir (Wien). 2001;143(5):429-48; discussion 448-9. doi: 10.1007/s007010170072.

Reference Type BACKGROUND
PMID: 11482693 (View on PubMed)

Kataoka K, Taneda M, Asai T, Kinoshita A, Ito M, Kuroda R. Structural fragility and inflammatory response of ruptured cerebral aneurysms. A comparative study between ruptured and unruptured cerebral aneurysms. Stroke. 1999 Jul;30(7):1396-401. doi: 10.1161/01.str.30.7.1396.

Reference Type BACKGROUND
PMID: 10390313 (View on PubMed)

Chyatte D, Bruno G, Desai S, Todor DR. Inflammation and intracranial aneurysms. Neurosurgery. 1999 Nov;45(5):1137-46; discussion 1146-7. doi: 10.1097/00006123-199911000-00024.

Reference Type BACKGROUND
PMID: 10549930 (View on PubMed)

Bruno G, Todor R, Lewis I, Chyatte D. Vascular extracellular matrix remodeling in cerebral aneurysms. J Neurosurg. 1998 Sep;89(3):431-40. doi: 10.3171/jns.1998.89.3.0431.

Reference Type BACKGROUND
PMID: 9724118 (View on PubMed)

Nakajima N, Nagahiro S, Sano T, Satomi J, Satoh K. Phenotypic modulation of smooth muscle cells in human cerebral aneurysmal walls. Acta Neuropathol. 2000 Nov;100(5):475-80. doi: 10.1007/s004010000220.

Reference Type BACKGROUND
PMID: 11045669 (View on PubMed)

Kosierkiewicz TA, Factor SM, Dickson DW. Immunocytochemical studies of atherosclerotic lesions of cerebral berry aneurysms. J Neuropathol Exp Neurol. 1994 Jul;53(4):399-406. doi: 10.1097/00005072-199407000-00012.

Reference Type BACKGROUND
PMID: 8021714 (View on PubMed)

Aydin F. Do human intracranial arteries lack vasa vasorum? A comparative immunohistochemical study of intracranial and systemic arteries. Acta Neuropathol. 1998 Jul;96(1):22-8. doi: 10.1007/s004010050856.

Reference Type BACKGROUND
PMID: 9678510 (View on PubMed)

Ushikoshi S, Kikuchi Y, Houkin K, Miyasaka K, Abe H. Aggravation of brainstem symptoms caused by a large superior cerebellar artery aneurysm after embolization by Guglielmi detachable coils--case report. Neurol Med Chir (Tokyo). 1999 Jul;39(7):524-9. doi: 10.2176/nmc.39.524.

Reference Type BACKGROUND
PMID: 10437381 (View on PubMed)

Meyers PM, Lavine SD, Fitzsimmons BF, Commichau C, Parra A, Mayer SA, Solomon RA, Connolly ES Jr. Chemical meningitis after cerebral aneurysm treatment using two second-generation aneurysm coils: report of two cases. Neurosurgery. 2004 Nov;55(5):1222. doi: 10.1227/01.neu.0000140987.71791.df.

Reference Type BACKGROUND
PMID: 15791738 (View on PubMed)

Berenstein A, Song JK, Niimi Y, Namba K, Heran NS, Brisman JL, Nahoum MC, Madrid M, Langer DJ, Kupersmith MJ. Treatment of cerebral aneurysms with hydrogel-coated platinum coils (HydroCoil): early single-center experience. AJNR Am J Neuroradiol. 2006 Oct;27(9):1834-40.

Reference Type BACKGROUND
PMID: 17032853 (View on PubMed)

Bendszus M, Solymosi L. Cerecyte coils in the treatment of intracranial aneurysms: a preliminary clinical study. AJNR Am J Neuroradiol. 2006 Nov-Dec;27(10):2053-7.

Reference Type BACKGROUND
PMID: 17110665 (View on PubMed)

Deshaies EM, Adamo MA, Boulos AS. A prospective single-center analysis of the safety and efficacy of the hydrocoil embolization system for the treatment of intracranial aneurysms. J Neurosurg. 2007 Feb;106(2):226-33. doi: 10.3171/jns.2007.106.2.226.

Reference Type BACKGROUND
PMID: 17410704 (View on PubMed)

Im SH, Han MH, Kwon BJ, Jung C, Kim JE, Han DH. Aseptic meningitis after embolization of cerebral aneurysms using hydrogel-coated coils: report of three cases. AJNR Am J Neuroradiol. 2007 Mar;28(3):511-2.

Reference Type BACKGROUND
PMID: 17353325 (View on PubMed)

Stracke CP, Krings T, Moller-Hartmann W, Mahdavi A, Klug N. Severe inflammatory reaction of the optic system after endovascular treatment of a supraophthalmic aneurysm with bioactive coils. AJNR Am J Neuroradiol. 2007 Aug;28(7):1401-2. doi: 10.3174/ajnr.A0550.

Reference Type BACKGROUND
PMID: 17698551 (View on PubMed)

Schmidt GW, Oster SF, Golnik KC, Tumialan LM, Biousse V, Turbin R, Prestigiacomo CJ, Miller NR. Isolated progressive visual loss after coiling of paraclinoid aneurysms. AJNR Am J Neuroradiol. 2007 Nov-Dec;28(10):1882-9. doi: 10.3174/ajnr.A0690.

Reference Type BACKGROUND
PMID: 17998416 (View on PubMed)

Kang HS, Han MH, Lee TH, Shin YS, Roh HG, Kwon OK, Kwon BJ, Kim SY, Kim SH, Byun HS. Embolization of intracranial aneurysms with hydrogel-coated coils: result of a Korean multicenter trial. Neurosurgery. 2007 Jul;61(1):51-8; discussion 58-9. doi: 10.1227/01.neu.0000279723.67779.f0.

Reference Type BACKGROUND
PMID: 17621018 (View on PubMed)

Pickett GE, Laitt RD, Herwadkar A, Hughes DG. Visual pathway compromise after hydrocoil treatment of large ophthalmic aneurysms. Neurosurgery. 2007 Oct;61(4):E873-4; discussion E874. doi: 10.1227/01.NEU.0000298918.55119.7C.

Reference Type BACKGROUND
PMID: 17986922 (View on PubMed)

Horie N, Kitagawa N, Morikawa M, Tsutsumi K, Kaminogo M, Nagata I. Progressive perianeurysmal edema induced after endovascular coil embolization. Report of three cases and review of the literature. J Neurosurg. 2007 May;106(5):916-20. doi: 10.3171/jns.2007.106.5.916.

Reference Type BACKGROUND
PMID: 17542541 (View on PubMed)

Marchan EM, Sekula RF Jr, Ku A, Williams R, O'Neill BR, Wilberger JE, Quigley MR. Hydrogel coil-related delayed hydrocephalus in patients with unruptured aneurysms. J Neurosurg. 2008 Aug;109(2):186-90. doi: 10.3171/JNS/2008/109/8/0186.

Reference Type BACKGROUND
PMID: 18671628 (View on PubMed)

Fanning NF, Willinsky RA, ter Brugge KG. Wall enhancement, edema, and hydrocephalus after endovascular coil occlusion of intradural cerebral aneurysms. J Neurosurg. 2008 Jun;108(6):1074-86. doi: 10.3171/JNS/2008/108/6/1074.

Reference Type BACKGROUND
PMID: 18518706 (View on PubMed)

White JB, Cloft HJ, Kallmes DF. But did you use HydroCoil? Perianeurysmal edema and hydrocephalus with bare platinum coils. AJNR Am J Neuroradiol. 2008 Feb;29(2):299-300. doi: 10.3174/ajnr.A0877. Epub 2007 Nov 16.

Reference Type BACKGROUND
PMID: 18024573 (View on PubMed)

Marden FA, Putman CM. Perianeurysm edema with second-generation bioactive coils. Surg Neurol. 2008 Jun;69(6):627-32; discussion 632. doi: 10.1016/j.surneu.2007.01.069. Epub 2007 Oct 31.

Reference Type BACKGROUND
PMID: 17976696 (View on PubMed)

Turner RD, Byrne JV, Kelly ME, Mitsos AP, Gonugunta V, Lalloo S, Rasmussen PA, Fiorella D. Delayed visual deficits and monocular blindness after endovascular treatment of large and giant paraophthalmic aneurysms. Neurosurgery. 2008 Sep;63(3):469-74; discussion 474-5. doi: 10.1227/01.NEU.0000324730.37144.4B.

Reference Type BACKGROUND
PMID: 18812958 (View on PubMed)

Im SH, Han MH, Kwon OK, Kwon BJ, Kim SH, Kim JE, Oh CW. Endovascular coil embolization of 435 small asymptomatic unruptured intracranial aneurysms: procedural morbidity and patient outcome. AJNR Am J Neuroradiol. 2009 Jan;30(1):79-84. doi: 10.3174/ajnr.A1290. Epub 2008 Sep 3.

Reference Type BACKGROUND
PMID: 18768715 (View on PubMed)

Killer M, Baltsavias G, Huemer M, Richling B. Visual worsening after incomplete coiling of a small asymptomatic aneurysm: case report and review of the literature. Minim Invasive Neurosurg. 2009 Feb;52(1):39-43. doi: 10.1055/s-0028-1104565. Epub 2009 Feb 26.

Reference Type BACKGROUND
PMID: 19247904 (View on PubMed)

Nishino K, Ito Y, Hasegawa H, Shimbo J, Kikuchi B, Fujii Y. Development of cranial nerve palsy shortly after endosaccular embolization for asymptomatic cerebral aneurysm: report of two cases and literature review. Acta Neurochir (Wien). 2009 Apr;151(4):379-83. doi: 10.1007/s00701-009-0234-4. Epub 2009 Mar 5.

Reference Type BACKGROUND
PMID: 19262981 (View on PubMed)

Hara A, Yoshimi N, Mori H. Evidence for apoptosis in human intracranial aneurysms. Neurol Res. 1998 Mar;20(2):127-30. doi: 10.1080/01616412.1998.11740494.

Reference Type BACKGROUND
PMID: 9522347 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

20137

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

MRI Analysis in the Growth of Cerebral Aneurysms
NCT06705452 NOT_YET_RECRUITING NA
Biomarkers of CASH
NCT04467489 ACTIVE_NOT_RECRUITING